Viromed Medical AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Cap	164	81	50	-	-
Market Cap Growth	124.45%	60.48%	-	-	-
Enterprise Value	163.27	80.52	52.26	0	0
Last Close Price	7.70	3.80	2.48	-	-
PE Ratio	270.68	-	16.24	-	-
PS Ratio	32.16	10.95	42.76	-	-
PB Ratio	15.62	7.69	6.95	-	-
P/TBV Ratio	20.69	10.21	7.89	-	-
P/FCF Ratio	-	22.83	-	-	-
P/OCF Ratio	-	21.91	-	-	-
EV/Sales Ratio	32.09	10.94	44.50	-	-
EV/FCF Ratio	-	22.81	-	-	-
Debt / Equity Ratio	0.03	0.03	0.00	0	0
Debt / FCF Ratio	0.08	0.08	-	-	-
Net Debt / Equity Ratio	-0.01	-0.01	0.00	-0.01	-0.01
Net Debt / EBITDA Ratio	0.21	0.21	0.00	0.54	0.94
Net Debt / FCF Ratio	-0.02	-0.02	0.03	-	-
Asset Turnover	0.54	0.54	0.07	0	0.00
Quick Ratio	0.47	0.47	0.04	0.55	0.87
Current Ratio	1.77	1.77	2.24	0.58	0.87
Return on Equity (ROE)	5.75%	5.75%	-20.90%	-0.55%	-0.80%
Return on Assets (ROA)	5.54%	5.54%	-15.58%	-1.77%	-0.79%
Return on Invested Capital (ROIC)	7.27%	7.69%	-17.89%	-1.79%	-0.80%
Return on Capital Employed (ROCE)	-8.65%	-8.65%	-23.93%	-1.79%	-0.80%
Earnings Yield	0.37%	-	6.16%	-	-
FCF Yield	-	4.38%	-	-	-
Buyback Yield / Dilution	-4.94%	-4.73%	0.00%	-	-
Total Shareholder Return	-4.94%	-4.73%	0.00%	-	-